TipRanks
Bafna Pharmaceuticals Limited (IN:BAFNAPH)
:BAFNAPH
India Market
BAFNAPH
Bafna Pharmaceuticals Limited
RESEARCH TOOLSreports
Want to see IN:BAFNAPH full AI Analyst Report?

Bafna Pharmaceuticals Limited (BAFNAPH) Income Statement

0 Followers

Bafna Pharmaceuticals Limited Income Statement

Last quarter (Q1 2027), Bafna Pharmaceuticals Limited's total revenue was ₹284.94M, a decrease of -17.70% from the same quarter last year. In Q1, Bafna Pharmaceuticals Limited's net income was ₹751.00K. See Bafna Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
₹ 1.51B₹ 1.46B₹ 1.52B₹ 1.15B₹ 851.40M
Gross Profit
₹ 201.42M₹ 168.77M₹ 452.15M₹ 175.56M₹ 137.18M
Operating Expenses
₹ 102.67M₹ 105.89M₹ 214.49M₹ 71.63M₹ 272.51M
Depreciation and Amortization
₹ 60.73M₹ 48.90M₹ 49.95M₹ 53.34M₹ 54.93M
EBITDA
₹ 207.04M₹ 117.73M₹ 146.34M₹ 189.88M₹ 112.34M
Operating Income
₹ 98.75M₹ 62.87M₹ 63.51M₹ 103.92M₹ 64.98M
Other Income/Expenses
₹ 10.95M₹ -21.35M₹ -164.18M₹ 12.24M₹ -12.82M
Pretax Income
₹ 109.70M₹ 41.52M₹ 73.48M₹ 116.16M₹ 52.16M
Net Income
₹ 111.00M₹ 41.52M₹ 73.48M₹ 113.38M₹ 52.16M
Per Share Metrics
Basic EPS
₹ 4.69₹ 1.76₹ 3.11₹ 4.79₹ 2.21
Diluted EPS
₹ 4.69₹ 1.76₹ 3.11₹ 4.79₹ 2.21
Weighted Average Shares Outstanding
 23.67M 23.69M 23.63M 23.66M 23.66M
Weighted Average Shares Outstanding (Diluted)
 23.67M 23.69M 23.66M 23.66M 23.66M
Currency in INR

Bafna Pharmaceuticals Limited Earnings and Revenue History